Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vericel Corporation - Common Stock
(NQ:
VCEL
)
41.12
+0.77 (+1.90%)
Streaming Delayed Price
Updated: 11:45 AM EST, Jan 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences
March 04, 2025
From
Vericel Corporation
Via
GlobeNewswire
Where Vericel Stands With Analysts
↗
February 28, 2025
Via
Benzinga
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
February 27, 2025
From
Vericel Corporation
Via
GlobeNewswire
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
What 7 Analyst Ratings Have To Say About Vericel
↗
February 03, 2025
Via
Benzinga
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
↗
January 15, 2025
Via
Benzinga
Earnings Preview For Vericel
↗
November 06, 2024
Via
Benzinga
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
February 13, 2025
From
Vericel Corporation
Via
GlobeNewswire
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
January 15, 2025
Via
Benzinga
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
January 14, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
January 08, 2025
From
Vericel Corporation
Via
GlobeNewswire
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
↗
August 27, 2024
Via
Benzinga
Expert Ratings For Vericel
↗
August 09, 2024
Via
Benzinga
Vericel Stock Sees RS Rating Shoot Higher
↗
November 11, 2024
The Relative Strength (RS) Rating for Vericel stock entered a higher percentile Monday, as it got a lift from 69 to 79.
Via
Investor's Business Daily
Smaller Cap Biotechs Are In Season: How Are We Doing?
↗
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Vericel Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
The Latest Analyst Ratings For Vericel
↗
August 02, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts
↗
July 16, 2024
Via
Benzinga
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
August 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
August 26, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
↗
August 02, 2024
Via
Benzinga
Vericel Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
Vericel Corporation
Via
GlobeNewswire
Trading SMID Biotech Stocks In A Volatile Market
↗
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
The 3 Highest-Rated Medical Stocks You Can Buy Today
↗
June 27, 2024
Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
